Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Colorectal cancer metastatic

Recruiting

Registered drugNo placebo

Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

Registered drugNo placebo

Austria

Participants:18–64 years
Substances:Bevacizumab

Contact Research Centre

Asthma

Recruiting

InvestigationalNo placebo

Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years

Contact Research Centre

Breast cancer

Recruiting

Registered drug

Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Chronic spontaneous urticaria

Recruiting

Registered drug

A study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Loratadine

Contact Research Centre

Crohn's disease

Recruiting

Investigational

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Crohn's disease

Recruiting

Investigational

A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease

Investigational

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Duvakitug

Contact Research Centre

Non-small cell lung cancer+1

Recruiting

Registered drugNo placebo

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

Registered drug

A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Empasiprubart

Contact Research Centre

Sjogren's syndrome

Recruiting

InvestigationalNo placebo

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Dazodalibep

Contact Research Centre

Small cell lung cancer+2

Recruiting

Registered drugNo placebo

Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Bronchiectasis

Recruiting

Investigational

A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:GSK3862995B

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:XMAB942

Contact Research Centre

Find therapies in clinical trials near you – page 5

10 246 trials match your criteria

Colorectal cancer metastatic

Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

Asthma

Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma

Breast cancer

Study of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer

Chronic spontaneous urticaria

A study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)

Crohn's disease

A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease

Crohn's disease

A study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease

Non-small cell lung cancer+1

Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC

Chronic inflammatory demyelinating polyradiculoneuropathy

A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

Sjogren's syndrome

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

Small cell lung cancer+2

Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

Bronchiectasis

A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

Colitis ulcerative

A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.